FIELD: medicine, pharmaceutics.
SUBSTANCE: invention discloses an antibody (versions) possessing immunologic responsiveness to incomplete polypeptide CAPRIN-1 (the amino acid sequences are presented in the description), and a pharmaceutical composition (versions) for treating and/or preventing a malignant growth, particularly breast cancer, cerebral tumour, leukaemia, lymphoma, lung cancer, or colon cancer. As an active ingredient, the composition contains an antibody or a fragment thereof possessing immunologic responsiveness to the protein CAPRIN-1 or a fragment thereof containing 7 more or more sequential amino acids. The antibody can be monoclonal, polyclonal, human, humanised, chimeric, single-chain or bispecific antibody. What is disclosed is a method of treating and/or preventing a malignant growth with using the antibody or the immunologically active fragment thereof.
EFFECT: antibodies according to the invention show the pronounced antitumour effect particularled ensured by their ability to damage the tumour cells expressing CAPRIN-1, and are attractive for treating the oncological diseases.
22 cl, 10 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2641260C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2595400C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING MALIGNANT GROWTH | 2012 |
|
RU2610428C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION | 2012 |
|
RU2611197C2 |
DRUGS FOR CANCER TREATMENT AND/OR PREVENTION | 2011 |
|
RU2624029C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND PREVENTION | 2012 |
|
RU2624049C2 |
PHARMACEUTICAL COMPOSITION FOR PANCREATIC CANCER TREATMENT AND/OR PREVENTION | 2012 |
|
RU2630638C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2011 |
|
RU2603742C2 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF CANCER | 2014 |
|
RU2678138C2 |
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT OR PREVENTION | 2013 |
|
RU2631804C2 |
Authors
Dates
2013-11-20—Published
2009-08-05—Filed